Predictive Oncology Initiates $2.2M Direct Stock Offering

Dec

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec

Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec

Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

Menu

Predictive Oncology Initiates $2.2M Direct Stock Offering

To read the full story....

Breaking News

Molecular Changes Wrought by Spaceflight Explored in Newly Published Studies

Recurrent SARS-CoV-2 Virus Mutations Do Not Increase Transmissibility, Study Finds

Somalogic Closes $121M Series A Funding

Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Recent Headlines from
Precision Oncology News

SEngine Precision Medicine IDs Potential Ovarian Cancer Treatment Combos Using Organoid Approach

Reinsurer SCOR Offering Cancer Genomic Testing as Benefit for Policyholders, Life Insurance Clients

Cancer Patients With BRCA1/2 Mutations Respond Differently to Immunotherapy, Study Shows

Radiomics-Based Method Detects EGFR Mutation Status, Predicts NSCLC Therapy Benefit

Early Data in Hand, Verastem Marches Ahead With RAF-MEK Inhibitor Program in KRAS-mutated Cancers

Featured White Papers

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

What's Popular?

Tempus Gets CE Mark for xT Tumor Sequencing Assay

European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx

FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

Sponsorships